CLINICAL_TRIALS
trial_result
· 2015-01-05
Clinical Trial Update: Decitabine in Treating Patients With Myelofibrosis [Phase 2]
Summary
Phase 2 results from a decitabine trial in myelofibrosis have been posted. The study is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Primary Myelofibrosis, Secondary Myelofibrosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2015-01-05